All Studies

Clinical studies across digestive health, migraine, skin and wellbeing show that removing foods identified by IgG testing is associated with meaningful symptom improvement.

Study Condition Participants Study Type Duration What improved Evidence Strength
Singh et al. 2025 IBS IgG trial IBS 223 Randomised, double-blind, sham-controlled 8 weeks More people achieved ≥30% reduction in abdominal pain vs control 🟢 Strong
Atkinson et al. 2004 IBS IgG trial IBS 150 Randomised, double-blind, sham-controlled 12 weeks ~10% greater symptom improvement vs control, up to 2× greater with adherence 🟢 Strong
Ostrowska et al. 2021 IgG vs FODMAP IBS study IBS 73 Comparative (IgG vs FODMAP vs control) 8 weeks Greater symptom and QoL improvement vs FODMAP and control 🟡 Moderate
Alpay et al. 2010 migraine IgG trial Migraine 30 Double-blind, cross-over 6 + 6 weeks Fewer migraine attacks and headache days 🟢 Strong
Zhao et al. 2025 migraine IgG cytokine study Migraine 60 Controlled intervention 12 weeks Fewer migraines + reduced IL-6, TNF-α, CGRP 🟡 Moderate
Bentz et al. 2010 Crohn's IgG trial Crohn's disease 40 Double-blind, cross-over 6 + 6 weeks Reduced digestive symptoms vs control 🟡 Moderate
Maiprasert et al. 2024 acne IgG RCT Acne 75 Randomised controlled trial 12 weeks Reduced acne severity (~33% in examples) 🟢 Strong
Kostić-Vučićević et al. 2017 Med Sport study Athletes / wellbeing 22 Pilot (no control) 3 months ~40% reduction in indigestion, improved recovery 🔵 Early
Hardman and Hart 2007 IgG survey study Mixed chronic symptoms 5,286 Observational survey 3 months ~72–76% reported symptom improvement 🔵 Early

How to read this table

  • 🟢 Strong evidence → Randomised controlled trials (highest confidence)
  • 🟡 Moderate evidence → Controlled or comparative studies
  • 🔵 Early evidence → Pilot or real-world observational data

Key patterns across studies

1. Consistent symptom improvement

Across multiple conditions:

  • Digestive symptoms
  • Migraine
  • Skin
  • General wellbeing

Most studies report improvement when foods identified by IgG testing are removed.

2. Strongest evidence in IBS and migraine

  • Multiple controlled trials
  • Clinically meaningful outcomes (e.g. ≥30% pain reduction)

3. Personalised diets outperform general approaches

IgG-guided diets vs:

  • Sham diets
  • Standard diets
  • FODMAP

Targeted removal appears more effective than broad restriction.

4. Evidence of biological effect

  • Reduction in inflammatory markers (IL-6, TNF-α)
  • Reduction in CGRP (migraine pathway)

Supports a mechanistic link, not just symptom reporting.


Explore individual studies

Supply Life

Unlock your full potential today

Get your easy to use food intolerance test today

Discover Products

Order Now
Supply Life

Unlock your full potential today

Get your easy to use food intolerance test today

Discover Products

Order Now